London’s Health Care Industry Booms as Millions are saved for the NHS

London’s Health Care Industry Booms as Millions are saved for the NHS

DigitalHealth.London have launched their impact report confirming they are speeding up digital innovations across health and care in London, creating jobs and saving millions of pounds for the NHS. This supports the objects of the Government’s Long Term Plan to make digitally-enabled care the mainstream across the NHS.

DigitalHealth.London is a collaborative programme delivered by MedCity, and London’s three Academic Health Science Networks (AHSN) – UCLPartners, Imperial College Health Partners, and the Health Innovation Network (HIN). It is supported by NHS England (London) and the Mayor’s Office.

The DigitalHealth.London Accelerator is a flagship programme delivered by DigitalHealth.London to fast track innovations into the NHS and support innovators navigating the NHS system. Around 20-30 companies are selected onto the Accelerator programme each year and are given bespoke mentoring, training, networking opportunities to develop their business. This collaboration and support also enables the fast spread of cutting edge innovations into the NHS to benefit patients and support NHS staff. The Accelerator companies range in size when they begin the programme, from a single founder working on one product, to companies with in excess of 30 employees.

467 new jobs were created

Eighty-five percent of companies to have been on the Accelerator programme who participated in this report, reported an increase in their staff numbers. Of the additional jobs created by companies on both the 2016-17 and 2017-18 programmes, 30.3 percent (141) are attributed to their involvement in the DigitalHealth.London Accelerator. A total of 467 new jobs were created between August 2016 and November 2018.

“Anything we achieve as a company is in some way down to, or connected to, working with the Accelerator.” Elliott Engers, CEO, Infinity Health, Accelerator cohort 2017-2018

Over £64 million of investment raised by Accelerator companies

As discovered by the recently published report DigitalHealth.London Accelerator companies raised over £64 million of investment between August 2016 – November 2018. One company alone account for £28 million of this. Sixty-six percent said that the DigitalHealth.London Accelerator had helped them raise investment in their company.

“The DigitalHealth.London Accelerator is saving millions of pounds for the NHS while stimulating economic growth in the health care industry.  It supports innovations that will change the lives of patients, support NHS staff and create jobs.” Tara Donnelly, Chief Digital Officer of NHSx 

NHS Savings almost £76 million

The work of Accelerator companies has resulted in almost £76 million in savings for the NHS, with just over a third of this (£24.8 million) credited to the Accelerator’s support, based on information self-reported by companies involved. A conservative view that 50 per cent of the NHS savings attributed to the Accelerator are actually being realised, given that the Accelerator programme is 50 per cent supported by AHSNs (the innovation arm of the NHS) and their partners MedCity and CW+, the Accelerator programme has a return on investment of over 14 times: for every £1 spent by the NHS (via AHSNs) on the DigitalHealth.London Accelerator, £14.60 is returned, in some way, through the implementation of a digital solution. Some of these savings are made in efficiency gains, for example finding more efficient ways of supporting patients to manage their own health conditions, whilst others may help reduce inappropriate urgent care attendances by providing easier access to GP services.

Read the full impact report here.

 

South London NHS Innovation and Research Priorities Highlighted

South London NHS Innovation and Research Priorities Highlighted

Following a national consultation of key local health stakeholders conducted across all regions in England, the NHS innovation and research priorities for south London have been outlined in the regional statement from the Health Innovation Network.

The views of clinical leaders, managers and directors within each Academic Health Science Networks (AHSN) region were collected through qualitative interviews with 61 people and a questionnaire which received more than 250 responses in total. The survey was conducted by ComRes, an independent research agency.

This widespread consultation was commissioned by the AHSN Network, in partnership with NHS England and the National Institute for Health Research (NIHR) to inform the publication of a statement of local NHS research and innovation needs for each AHSN region – as one of the actions in the NHS England and NIHR joint paper on ‘12 actions to support research in the NHS’.

Whilst there were some differences in regional priorities, common themes emerged which reflected both south London priorities and wider challenges facing the NHS and align with the priorities of the NHS Long Term Plan. These include:

  • a need for innovation and research addressing  workforce challenges
  • delivery of mental health services and providing care for patients with mental health needs, particularly in children and young people
  • integrating services to provide effective care for patients with complex needs – including  multimorbidity and frailty
  • use of digital and artificial intelligence technology

The National Survey Full Report outlines the findings from the consultation with local health and social care stakeholders across England. It includes a detailed analysis of the innovation and research needs at local level across all AHSNs.

Natasha Curran, Medical Director, Health Innovation Network said: “Thank you to the south London stakeholders for their invaluable contributions. The statement provides a really useful starting point to build discussions with wider stakeholders, patients and others in the community to address the priorities outlined.”

Professor Gary Ford, Chief Executive of Oxford AHSN, led the AHSNs input into the survey. He said: “The survey provides important information on the research and innovation needs of the NHS which will shape future work of AHSNs and the research community”.

Think Diabetes Report calls on London employers to better support staff living with diabetes

Think Diabetes Report calls on London employers to better support staff living with diabetes

London employers are being urged to ‘Think Diabetes’ in the workplace in a new report published by the Health Innovation Network. Figures in the report show a major gap in the number of with people living with Type 1 and Type 2 diabetes attending free educational programmes to help them learn about their condition and live healthier lives.

There were more than 3.1 million people  diagnosed with Type 1 and Type 2 diabetes  in England in 2017-18 and it is estimated that in London over 671,000 people of working age (over the age of 16) have  either Type 1 or Type 2  diabetes. But the Think Diabetes Report shows less than 8 percent of eligible Londoners living with Type 2 diabetes are attending these courses (this figure is less than 9 percent of eligible people across England).

Reasons for people not attending these courses are varied, but previous reports have cited ‘time off work’ as one of the key issues.  Given the potential for employers to support staff with health, the Think Diabetes report makes a series of recommendations on how employers can help support their staff to take advantage of the education opportunities available to them, or even provide education for staff themselves.

To celebrate the launch of the report, we partnered with Diabetes  UK  to deliver the Think Diabetes Summit. The event brought employers, diabetes experts and patients together, to discuss ways in which organisations can support their staff including; running education sessions in the workplace, sharing new digital approaches to education with their teams so staff can complete these courses online and by making sure staff are supported to take time off work for education to help them live with a long-term health condition.

Diabetes is covered by the Equality Act 2010 as a long-term condition that has significant impact on individuals’  lives and employers are therefore obliged to make reasonable adjustments, although these adjustments are not defined. The case for employers adjusting their policies and supporting individuals to attend structured education is overwhelming.

The event was chaired by Dr Neel  Basudev, Diabetes Clinical Director of the Health Innovation Network and GP in Lambeth, who said:

“Employers have huge influence over the lives of the working population and a unique opportunity to help with what is arguably the greatest challenge facing our nation’s health: diabetes.

“There are more ways for people to access vital education about diabetes than ever before, with many parts of the NHS innovating with digital courses and new approaches to offer support. We now need to raise awareness of what’s on offer and remove as many barriers as we can. Workplace barriers are some of the simplest to address and changes can be made to support staff that will increase the health and productivity of the workplace.”

As well as hearing from diabetes experts and representatives from the organisations who were case studies in the report, Deputy Leader of the Labour Party and Shadow Culture Minister Tom Watson MP shared how he self-managed his own type 2 diabetes into remission. A passionate advocate for helping people learn to self-manage, he said: 

“By changing my diet and lifestyle I’ve put my Type 2 diabetes into remission. I feel fitter, faster, and healthier than ever before and this has given me a new mission to help others get healthy.

“Supporting people who live with diabetes is a major challenge facing our society, and one in which we all have a part to play. Employers in particular can play a key role in supporting people in their journey to learn more about their condition, and how best to manage it.

“It is time employers think differently about diabetes in the workplace and the Think Diabetes Summit is bringing together key leaders from across businesses and organisations to do just that.”

The Think Diabetes Summit was attended by organisations that collectively employ thousands of Londoners. TechUK attended the event and their CEO Julian David said: “techUK represents the companies and technologies that are defining today the world that we will live in tomorrow. I feel passionately that our members should also be leaders in supporting and developing the workforce for the future.  Diabetes is an increasing problem in our society and employers should be engaging with innovative ways to help support staff living with Type 1 and Type 2 diabetes to better manage their condition.”

Download the Think Diabetes Report and Toolkit here.

New report maps the MedTech landscape for innovators in England

New report maps the MedTech landscape for innovators in England

The NHS spends approximately £6 billion a year on medical technology, also known as MedTech, such as medical devices, equipment and digital tools. It is an industry that accounts for over 86,000 jobs in the UK, almost a third of which are within small companies, and supports an additional 24,600 service and supply roles.

A new report from the AHSN Network provides an essential guide for companies looking to successfully develop and roll out innovations in this complex and diverse industry, focused around the MedTech innovation pathway. It includes a foreword by Piers Ricketts, Chief Executive of Eastern AHSN and Vice Chair of the AHSN Network.

The MedTech Landscape Review will be launched formally at an event to be held jointly with one of our partners, the Association of British HealthTech Industries (ABHI), on 20 March and introduced by Piers.

In the meantime, the report is available for download here, featuring case studies, statistics and practical advice for navigating each step of the MedTech Innovation pathway.

Adoption and spread of innovation in the NHS

Adoption and spread of innovation in the NHS

Boots on the ground, local freedoms and supportive leaders: ingredients for successful spread of innovation detailed in new report.

A new report from The King’s Fund, published today and commissioned on behalf of the AHSN Network, charts the journeys of eight innovations from creation to widespread use.

From new communication technologies for patients with long-term conditions, to new care pathways in liver disease diagnosis, to new checklists for busy A&E departments, the report details the highs and lows of an innovator’s journey through the NHS.

While thousands of patients are now receiving new innovative treatments for arthritis, diabetes, cardiovascular disease and chronic liver disease, thanks to successful innovations, the report outlines the significant barriers that stand in innovators’ paths.

The case studies reveal common themes:

  • New innovations may appear simple to introduce but can have a domino effect – triggering a series of changes to diagnosis and treatment, revealing new patient needs and resulting in big changes to staff and patient roles. That’s why staff need time and resources to implement them.
  • As long as the NHS sets aside less than 0.1% of available resources for the adoption and spread of innovation, a small fraction of the funds available for innovation itself, the NHS’s operating units will struggle to adopt large numbers of innovations and rapidly improve productivity.
  • Fragmentation of NHS services remains a barrier to adoption and spread of innovation, making it harder to develop shared approaches and transmit learning across sites.
  • Providers need to be able to select and tailor innovations that deliver the greatest value given local challenges and work in the local context.

Read the report in full here.

The findings of the report will be discussed in depth at a live online event hosted by The King’s Fund on 19 January at 10am. Register and more details here.

England’s 15 AHSNs were set up by the NHS in 2013. They bring together the NHS, social care, public health, academic, voluntary and industry organisations to support the spread of innovation throughout the NHS and care. During their first licence (since 2013) they have spread over 200 innovations through 11,000 locations, benefiting 6 million people, creating over 500 jobs and leveraging £330 million investment to improve health and support the NHS, social care and industry innovators.